Authors
Latest:
The Death Knell of Pharma HCP WebsitesShould pharma brands still maintain dedicated websites to engage HCPs? Are they effective and trustworthy sources of information that offer intuitive and helpful experiences for the user?
Latest:
Where Caremark Meets Park: A New Era of Regulatory Compliance and Criminal LiabilityThe Caremark and Park doctrines require directors and managers of life sciences companies to address regulatory compliance proactively and vigorously.
Latest:
Twenty Years of GrowthLearn how Frontage Laboratories started, recent growth and expansion, and the future vision of Frontage
Latest:
Fast-Track Your Real World Data SearchNow Available On Demand! Join this webinar to learn a new way to quickly identify the right real world data sources. IQVIA Health Data Catalog makes assessing RWD fast and easy with 2000+ unique global data assets, 200+ variables describing patient data, and up-to-date profiles to efficiently compare which is most relevant for your project.
Latest:
Are We Entering the Nuclear Medicine Industrial Revolution?Achieving better outcomes for patients and advancing the fields of nuclear medicine and oncology are not just about adopting new technologies, but also about embracing a profound change in how care is delivered.
Latest:
Three Ways Life Sciences Can Educate Stakeholders About BiosimilarsThere are several strategies life sciences companies can use to benefit from biosimilars.
Latest:
Unlocking the Potential of AI in Healthcare–5 Key TakeawaysThe technology has the potential to be implemented across multiple aspects of the industry.
Latest:
The Impact of Mergers and Acquisitions on Brand in the Life Sciences IndustryLaura Child, Head of Research and Strategy at ramarketing, discusses the importance of brand reputation and the effect brand architecture associated with merger and acquisition (M&A) can have on a company’s brand.
Latest:
The Legal Environment for IVF and Other Assistive Reproductive Technology After Alabama’s Supreme Court and Legislative DecisionsUnlike for individuals or entities providing or receiving services related to in vitro fertilization (IVF), the Alabama IVF Act does not grant immunity to manufacturers, but it limits damages for their violations to the cost of an IVF cycle.
Latest:
Expert Roundup: How Technology is Shaping the Future of Life SciencesIndustry leaders share perspectives on moving the life sciences industry forward.
Latest:
The Real Value of AI in Healthcare? Strengthening the Doctor-Patient RelationshipWhy empowering both parties with the tools and data they need to make clinical decisions should be a top priority in the AI renaissance—to bolster patient care and improve health outcomes.
Latest:
Bridging the Divide: Medical's Omnichannel MomentumHow pharma medical affairs and commercial teams are synchronizing their capabilities to boost omnichannel marketing strategies and better understand customer engagement needs.
Latest:
Moving Toward the Pharmaceutical Industry of the Future with Translational MedicineGabi Hanna, MD highlights the need for an effective therapy for acute pancreatitis.
Latest:
Executive Roundtable: Innovations in Global Pharma LabelingFive industry experts discuss labeling challenges and trends in modernization.
Latest:
2021 Preview: A 360-Degree Global Market ViewDonna L. LaVoie outlines the takeaways of a recent industry webinar discussing global trends on public and private markets, JPM virtual week, and more.
Latest:
Launch Lessons: Bringing a Targeted Oncology Therapy to MarketOmnichannel marketing can help companies improve HCP engagement to facilitate the delivery of effective treatment to patients who desperately need and deserve it.
Latest:
CDMOs are Exploring Risk-Sharing for Resilient Growth in a BANI WorldKey industry trends and how the relationships between companies and CDMOs are evolving to better meet the challenges of a BANI world.
Latest:
The Healthcare System is Changing—So How Should We Respond?What pharma needs to do to keep up with the rise in value-based care.
Latest:
Cracking Down on Speaker ProgramsWith heightened government scrutiny on educational forums, biopharma manufacturers need a sound framework that demonstrates they are following best practices.
Latest:
EU Medical Device Supply Chains and Trade Agreements: The COVID-19 ResponseAndrew Hood and Cliodhna McDonough look at the key issues necessary to support business and the community in developing a long-term and sustainable response to the challenges highlighted by COVID-19.
Latest:
How Market Access Can Determine Commercial SuccessUsing market access data from day one of your drug development and commercialization journey puts your brand in the best position to succeed at launch.
Latest:
How to Lead and Succeed in the Biosimilars SpaceKey traits needed by leaders looking to grow their organizations in the biosimilars market.
Latest:
Shedding Light on Global Pharmaceutical Supply ChainsIncrease in new treatments also brings increase in logistical challenges for pharma.
Latest:
Patients and Data Disrupt the Life Sciences IndustryDelivering better patient outcomes hinges on innovation and adaptability.
